
Elm Street Ventures
Description
Elm Street Ventures (ESVC) is a specialized venture capital firm headquartered in New Haven, Connecticut, with a distinct investment mandate. Its core strategy revolves around identifying, creating, and funding life sciences and technology companies that are built upon intellectual property originating from Yale University. This unique and deeply integrated relationship with Yale positions ESVC as a critical conduit for translating cutting-edge academic research into commercial enterprises, fostering innovation within the university's robust ecosystem.
The firm primarily deploys seed and early-stage capital, often adopting a highly engaged approach that extends beyond traditional investment. ESVC frequently plays an active role in the initial formation and operational development of its portfolio companies, reflecting a "company creator" model rather than just a passive investor. This hands-on involvement is crucial for guiding nascent ventures through their foundational stages, ensuring that promising technologies are properly structured and resourced for market entry and growth. Their focus remains on ventures with strong proprietary technology and significant market potential, leveraging Yale's extensive research and development capabilities.
Elm Street Ventures has successfully raised multiple funds to support its focused investment thesis. For example, their Elm Street Ventures V fund closed in 2017, securing $35 million in commitments, which followed their Elm Street Ventures IV fund that closed at $25 million in 2011. The firm typically invests initial checks ranging from $500,000 to $3 million in its portfolio companies, demonstrating their commitment to providing substantial early-stage support. Furthermore, ESVC strategically reserves capital for follow-on investments, enabling them to continue backing their companies through subsequent funding rounds as they achieve critical milestones and scale their operations. This long-term commitment underscores their dedication to nurturing the growth and success of Yale-derived innovations.
Investor Profile
Elm Street Ventures has backed more than 28 startups, with 1 new investments in the last 12 months alone. The firm has led 4 rounds, about 14% of its total and boasts 8 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series Unknown, Seed rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
- Typical check size: $500K – $3M.
Stage Focus
- Series A (43%)
- Series Unknown (21%)
- Seed (18%)
- Series B (14%)
- Series C (4%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Biopharma
- Medical
- Pharmaceutical
- Chemical
- Renewable Energy
- Software
- Oncology
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.